13% Mortality Rate in Fully Vaccinated Patients With Cancer Who Had Breakthrough COVID-19
Data were collected before booster vaccine recommendation. The first study to evaluate the clinical characteristics and outcomes of fully vaccinated patients with cancer who had breakthrough COVID-19 infections indicates they remained at high risk for hospitalization and death.